Version 2.80

Part Descriptions

LP28525-1   Naloxone
Naloxone is a pure opioid antagonist and, when taken at recommended doses, has no physiological effects in the absence of an opioid agonist. Intravenous naloxone becomes effective within two minutes of injection, but oral or sublingual naloxone has little effect due to its poor absorption. Therefore, intravenous naloxone is used to treat opioid overdose, and it is used as a sublingual combination with buprenorphine, an opioid agonist-antagonist used to treat chronic opioid-dependence, to lower buprenorphine's abuse potential as follows: when the combination is taken sublingually as prescribed, naloxone exerts little effect and buprenorphine's effects predominate; however, if crushed and injected intravenously, naloxone's antagonist properties reverse the agonist effects of buprenorphine and can precipitate withdrawal. PMID: 19368419 Nalaxone levels along with its inactive metabolite, naloxone-3-glucuronide (N3G), may be measured to monitor compliance or identify illicit opioid drug use. Source: Regenstrief LOINC , PMID: 19368419

LP32035-5   Creatinine
Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. It is transferred to the kidneys by blood plasma, whereupon it is eliminated by glomular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate and measuring its serum level is a simple test. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas. Copyright Copyright ©2005-2009 Genome Alberta (Reference to original publication: Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 37(Database issue):D603-610.) Source: Human Metabolome Database , Creatinine

Fully-Specified Name

Component
Naloxone/Creatinine
Property
MRto
Time
Pt
System
Urine
Scale
Qn
Method

Additional Names

Long Common Name
Naloxone/Creatinine [Mass Ratio] in Urine
Short Name
Naloxone/Creat Ur
Display Name
Naloxone/Creatinine (U) [Mass ratio]
Consumer Name Alpha Get Info
Naloxone/Creatinine, Urine

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.79
Last Updated
Version 2.79 (ADD)
Order vs. Observation
Both

Language Variants Get Info

Tag Language Translation
el-GR Greek (Greece) Ναλοξόνη/Κρεατινίνη:MRto:Pt:Ούρα:Qn:
Synonyms: MRto
es-ES Spanish (Spain) Naloxona/Creatinina:Relacion de Masa:Punto temporal:Orina:Qn:
Synonyms: Cuantitativo
et-EE Estonian (Estonia) Naloksoon/kreatiniin:MRto:Pt:U:Qn:
Synonyms: Juhuslik Kvantitatiivne Uriin
fr-CA French (Canada) Naloxone/Créatinine:Ratio de masse:Temps ponctuel:Urine:Quantitatif:
fr-BE French (Belgium) Naloxone/Créatinine:Ratio de masse:Temps ponctuel:Urine:Quantitatif:
Synonyms: Rapport de masse
it-IT Italian (Italy) Naloxone/Creatinina:MRto:Pt:Urine:Qn:
Synonyms: Livelli farmacologici e tossicologia Punto nel tempo (episodio) Rapporto di Massa
nl-NL Dutch (Netherlands) naloxon/creatinine:massaverhouding:moment:urine:kwantitatief:
Synonyms: kreatinine
ru-RU Russian (Russian Federation) Налоксон/Креатинин:МассОтн:ТчкВрм:Моча:Колич:
Synonyms: Количественный Масс отношение Точка во времени;Момент
tr-TR Turkish (Turkey) Nalokzon/Kreatinin:KütlOr:Zmlı:İdrar:Kant:
zh-CN Chinese (China) 钠洛酮/肌酐:质量比率:时间点:尿液:定量型:
Synonyms: C19H21NO4;纳洛酮;那诺松 CR;Creat;肌氨酸酐;肌酸内酰胺;肌酸酐 UCr 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 尿;小便;下泉 尿液肌酐 尿液肌酸酐 尿肌酸酐 时刻;随机;随意;瞬间 来自于同一体系的两种分析物的质量之比;质量比 毒品 毒品类 肌酸内酰胺 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类

Example Units

Unit Source
ng/mg{creat} Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=107257-8